期刊文献+

216例肝硬化患者预后多因素分析 被引量:6

Multivariate proportional hazards regression analysis of 216 hepatic cirrhosis patients
暂未订购
导出
摘要 目的了解影响肝硬化患者预后的主要指标。方法选择具有完整临床资料和随访结果的216例肝硬化患者进行回顾性分析。采用Kaplain-Meier法及Log-rank检验对50项指标进行单因素分析。再将单因素分析有意义的指标采用Cox回归模型进行多因素分析,筛选出影响预后的主要因素。结果多因素分析显示以下8项指标与肝硬化预后有显著相关性:总胆红素、肌酐、血浆凝血酶原时间、腹水、肝性脑病、年龄、天门冬酸氨基转移酶和碳酸氢根(P=0.000~0.018)。结论总胆红素、肌酐、血浆凝血酶原时间、腹水、肝性脑病、年龄、天门冬酸氨基转移酶和碳酸氢根是影响肝硬化预后的重要因素,建立预后评估模型时可考虑加入上述指标。 [Objective] To investigate the factors influencing the prognosis of hepatic cirrhosis. [Methods] A cohort of 216 patients with liver cirrhosis were retrospectively studied and followed up. 50 indexes were observed. Using Kaplan-Meier method and Log-rank test for univariate analysis. Using Cox proportional hazard regression for multivariate analysis. [Results] According to the multivariate Cox proportional hazard regression analysis, the factors that had significant influence on the prognosis of hepatic cirrhosis patients included: total bilirubin (TBIL), creatinine (Cr), prothrombin time (PT), ascites (AS), hepatic encephalopathy (HE), age, aspartate aminotransferase (AST), bicarbonate (HCO3) (P =0.000-0.018). [Conclusions] The factors that contributed to the prognosis were: TBIL, Cr, PT, AS, HE, age, AST, HCO3. These indexes might be included in a model to predict the prognosis of hepatic cirrhosis patients.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2007年第6期718-721,724,共5页 China Journal of Modern Medicine
关键词 肝硬化 预后 多因素分析 hepatic cirrhosis Prognosis multivariate analysis
  • 相关文献

参考文献10

  • 1KAMATH PS,WIESNER RH,MALINCHOC M,et al.A model to predict survival in patients with end-stage liver disease[J].Hepatology,2001,33(2):464-470.
  • 2孙永年,徐斌,黄祝青,黄长形.苦参素治疗对慢乙肝患者TGF - β1、TNF -α、HA、PcⅢ水平的影响(英文)[J].中国现代医学杂志,2004,14(3):41-44. 被引量:11
  • 3GIANNINI E,BOTTA F,TESTA E,et al.The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis[J].Am J Gastroenterol,2002,97(11):2855-2860.
  • 4HABIB A,MIHAS AA,ABOU-ASSI SG,et al.High-density lipoprotein cholesterol as an indicator of liver function and prognosis in noncholestatic cirrhotics[J].Clin Gastroenterol Hepatol,2005,3(3):286-291.
  • 5RUF AE,KREMERS WK,CHAVEZ LL,et al.Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone[J].Liver Transpl,2005,11(3):336-343.
  • 6HONG MH.Design Measurement Evaluation (the second edition)[M].Guangzhou:Zhong Shan University Publishing Company,2002:59.Chinese
  • 7ROBERT A,CHAZOUILLERES O.Prothrombin time in liver failure:time,ratio,activity percentage,or international normalized ratio[J].Hepatology,1996,24(6):1392-1394.
  • 8GHOBRIAL RM,GORNBEIN J,STEADMAN R,et al.Pretransplant model to Predict posttransplant survival in liver transplant patients[J].Ann Surg,2002,236(3):315-323.
  • 9HEUMAN DM,ABOU-ASSI SG,HABIB A,et al.Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death[J].Hepatology,2004,40(4):802-810.
  • 10SAAB S,IBRAHIM AB,SHPANER A,et al.MELD fails to measure quality of life in liver transplant candidates[J].Liver Transpl,2005,11(2):218-223.

二级参考文献2

共引文献10

同被引文献33

引证文献6

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部